Dabur India Limited · NSE:DABUR
Dabur India — Q4 FY25 Earnings Presentation
24 slides from Dabur India's earnings presentation, May 7, 2025
Slide 1: Stock exchange cover letter: Investor Communication
XJ^^At. ^^- ^< Ref: SEC/SE/2025-26 Date: May 07, 2025 India Ltd. To, Corporate Relations Department Listing Department BSE Ltd. National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor Dalal Street, Plot No. C/1, G Block, Bandra Kurla Complex Mumbai-400001 Bandra (E)
Slide 2: Investor Presentation Q4 FY24-25
Investor Presentation Q4 FY24-25 7th May 2025
Slide 3: Agenda
1. 2. 3. 4. FINANCIAL BUSINESS STRATEGY REFRESH P&L UPDATE HIGHLIGHTS HIGHLIGHTS
Slide 4: Financial Highlights
1 FINANCIAL BUSINESS STRATEGY REFRESH P&L UPDATE HIGHLIGHTS HIGHLIGHTS
Slide 5: FY25 snapshot
FY25 snapshot CONSOLIDATED INTERNATIONAL Revenue Operating profit Revenue INR INR INR 12,563 Cr 2,316 Cr 3,281 Cr 1.3% (3.5%) CC 17.2% Y-o-y growth Y-o-y Y-o-y growth Muted growth on account of one time inventory correction taken in Q2 to support partner ROIs in GT channel
Slide 6: FY25 Financial Highlights
FY25 Financial Highlights Revenue from Operating Profit Profit After Tax Operations 12,404 12,563 19.4% 18.4% 2,400 2,316 1,843 1,768 FY24 FY25 FY24 FY25 FY24 FY25 3.6% CC growth (3.5%) YoY (4.1%) YoY 1.3% INR growth Numbers in INR Crore Note: India FMCG includes Badshah
Slide 7: Verticals Contribution To Domestic FMCG Business in FY25
Verticals Contribution To Domestic FMCG Business in FY25 Home & Personal Care Health Care Foods & Beverages 49.7% 31.3% 2.0% 17.0% INR 4,179 Cr INR 2,631 Cr INR 165 Cr INR 1,433 Cr 0.5% YoY (2.2%) YoY 18.4% YoY (8.8%) YoY Note: Foods excludes Badshah
Slide 8: FY25 International Business Highlights
FY25 | International Business Highlights (CC growth) NAMASTE NA Turkey INR 3,281 Crore 5.8% 17.9% MENA Revenue from International Markets 15.3% Bangladesh ~26% contribution to 19.8% overall sales CC Growth: 17.2% INR Growth: 7.7% SSA Egypt 15.8% 55.3%
Slide 9: Q4 FY25 snapshot
Q4 FY25 snapshot CONSOLIDATED INTERNATIONAL Revenue Operating profit Revenue INR INR INR 2,830 Cr 427 Cr 814 Cr 0.6% (8.5%) CC 19.3% Y-o-y growth Y-o-y Y-o-y growth
Slide 10: Q4 FY25 Financial Highlights
Q4 FY25 Financial Highlights Revenue from Operating Profit Profit After Tax Operations 2,815 2,830 16.6% 15.1% 467 427 350 320 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 2.1% CC growth (8.5%) YoY (8.4%) YoY 0.6% INR growth Numbers in INR Crore Note: India FMCG includes Badshah
Slide 11: Verticals Contribution To Domestic FMCG Business in Q4 FY25
Verticals Contribution To Domestic FMCG Business in Q4 FY25 Home & Personal Care Health Care Foods & Beverages 48.3% 30.0% 2.0% 19.7% INR 863 Cr INR 536 Cr INR 37 Cr INR 352 Cr (3.3%) YoY (4.7%) YoY 14.2% YoY (9.2%) YoY Note: Foods excludes Badshah
Slide 12: Q4 FY25 International Business Highlights
Q4 FY25 | International Business Highlights (CC growth) NAMASTE NA Turkey INR 814 Crore 13.4% 23.4% MENA Revenue from International Markets 22.3% Bangladesh ~29% contribution to 22.0% overall sales CC Growth: 19.3% INR Growth: 13.4% SSA Egypt 19.8% 36.0%
Slide 13: Dividend Update
Dividend Update Interim Dividend Final dividend Total dividend Dividend per share 2.75 5.25 8.00 (INR) Dividend % 275% 525% 800% Total Dividend (INR 487.39 930.47 1,417.86 Cr)
Slide 14: Business Highlights
2 FINANCIAL BUSINESS STRATEGY REFRESH P&L UPDATE HIGHLIGHTS HIGHLIGHTS
Slide 15: Home & Personal Care
Home & Personal Care Value growth Q4 8.0% 0.9% -5.2% -4.6% Oral Care Hair Care Home Care Skin Care Oral care • Impacted on account of higher base effect (22% growth in Q4FY24); • Meswak and Dabur Herb’l portfolio performed well Hair care • Shampoo has grown in mid single digit; 20 bps market share g
Slide 16: Healthcare
Healthcare Value growth Q4 -2.1% -3.6% -8.4% Health Supplements OTC & Ethicals Digestives Health Supplements • Glucose registered 10% growth; gained 112 bps in market share • Delayed and contracted winters impacted Chyawanprash and Honey OTC & Ethicals • Health juices continued growth momentum with
Slide 17: Foods & Beverages
Foods & Beverages Value growth Q4 14.2% 6% -9.2% Beverages Foods Badshah Beverages: • Real gained 260 bps market share in the J&N category • Premium portfolio comprising Real Activ range and coconut water grew in double digits Foods: • Foods sustained its strong growth momentum with 14.2% growth y-o
Slide 18: Brand Building Initiatives
Brand Building Initiatives Superior Claims New Communications Ground Activations and Visibility India’s 1st Ayurvedic Toothpaste accepted by IDA Dabur Khajurprash Glucoplus C Dabur Honey – new campaign on weight management Meswak Cool King Talc Real Fizzin Real Mango
Slide 19: Strategy Refresh
3 FINANCIAL BUSINESS STRATEGY REFRESH P&L UPDATE HIGHLIGHTS HIGHLIGHTS
Slide 20: Refreshed Vision
Refreshed Vision Accelerate profitable growth 1 Continued confidence & 2 Premiumization and 3 Bold bets across Health & investment in core brands contemporization across Wellness spaces categories 4 Streamlined portfolio - Rationalisation of underperforming products/SKUs, releasing capital to focus
Slide 21: P&L Update
4 FINANCIAL BUSINESS STRATEGY REFRESH P&L UPDATE HIGHLIGHTS HIGHLIGHTS
Slide 22: Q4 FY25 and FY25 Consolidated P&L
Q4 FY25 and FY25 | Consolidated P&L In INR crores Q4 FY25 Q4 FY24 Y-o-Y (%) FY25 FY24 Y-o-Y (%) Revenue from operations 2,830.1 2,814.6 0.6% 12,563.1 12,404.0 1.3% Material Cost 1,509.1 1,446.8 4.3% 6,534.9 6,447.0 1.4% Employee expense 294.3 316.2 -6.9% 1,291.2 1,239.6 4.2% Advertisement and public
Slide 23: Q4 FY25 and FY25 Standalone P&L
Q4 FY25 and FY25 | Standalone P&L In INR crores Q4 FY25 Q4 FY24 Y-o-Y (%) FY25 FY24 Y-o-Y (%) Revenue from operations 1,964.7 2,039.5 -3.7% 9,070.7 9,135.6 -0.7% Material Cost 1,110.9 1,102.9 0.7% 4,962.0 4,928.5 0.7% Employee expense 160.2 194.3 -17.5% 776.9 782.1 -0.7% Advertisement and publicity
Slide 24: Disclaimer
Disclaimer Cautionary note concerning forward-looking statement Certain statements made in this presentation relating to the Company’s objectives, projections, outlook, expectations, estimates, among others may constitute ‘forward-looking statements’ within the meaning of applicable laws and regulat